Inventor · disambiguated record
Pilar Garin-Chesa
Also filed as: GARIN-CHESA PILAR
24 granted patents·11 pending applications·761 citations·filing 1988–2014
97Inventor score
Files withSLOAN KETTERING INST CANCER10LUDWIG INST CANCER RES9VAN RYN JOANNE4BOEHRINGER INGELHEIM INT3ADOLF GUENTHER2
Top patents by PatentIndex Score
35 records- 0193US6455677B1FAPα-specific antibody with improved producibilityBOEHRINGER INGELHEIM INT·Filed 1999·Granted Sep 24, 2002·103 cites·19 claims
- 0293US6310185B1Recombinant human anti-Lewis Y antibodiesSLOAN KETTERING INST CANCER·Filed 1994·Granted Oct 30, 2001·112 cites·6 claims
- 0390US6391302B1Method for treating cancers which present antigen FB5 with humanized antibodiesLUDWIG INST CANCER RES·Filed 2000·Granted May 21, 2002·18 cites·14 claims
- 0490US5342757AMonoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereofLUDWIG INST CANCER RES·Filed 1992·Granted Aug 30, 1994·69 cites·10 claims
- 0589US6613879B1FAP-activated anti-tumour compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Sep 2, 2003·46 cites·14 claims
- 0689US5952484ARecombinant human anti-LK26 antibodiesSLOAN KETTERING CANCER CENTER·Filed 1996·Granted Sep 14, 1999·84 cites·6 claims
- 0789US5646253ARecombinant human anti-LK26 antibodiesSLOAN KETTERING INST CANCER·Filed 1994·Granted Jul 8, 1997·58 cites·2 claims
- 0888US6348195B1Method for treating cancersSLOAN KETTERING INST CANCER·Filed 2000·Granted Feb 19, 2002·25 cites·9 claims
- 0987US5874060ARecombinant human anti-Lewis Y antibodiesSLOAN KETTERING INST CANCER·Filed 1997·Granted Feb 23, 1999·49 cites·7 claims
- 1080US6090930ARecombinant human anti-FB5 antibodiesLUDWIG INST CANCER RES·Filed 1998·Granted Jul 18, 2000·25 cites·8 claims
- 1176US5811522ARecombinant humanized anti-FB5 antibodiesLUDWIG INST CANCER RES·Filed 1996·Granted Sep 22, 1998·20 cites·17 claims
- 1275US6217868B1Methods for detecting cancer cells by using humanized antibodies which bind specifically to FB5 antigenLUDWIG INST CANCER RES·Filed 1998·Granted Apr 17, 2001·19 cites·31 claims
- 1375US6124106AMethod for detecting cancersLUDWIG INST CANCER RES·Filed 1999·Granted Sep 26, 2000·29 cites·15 claims
- 1471US7714010B2Pyrrolobenzimidazolones and their use as anti-proliferative agentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted May 11, 2010·2 cites·5 claims
- 1570US5587299AIsolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereofSLOAN KETTERING INST CANCER·Filed 1994·Granted Dec 24, 1996·30 cites·15 claims
- 1667US5843448ATumor rejection antigen precursorLUDWIG INST CANCER RES·Filed 1995·Granted Dec 1, 1998·22 cites·9 claims
- 1765US6518415B1Recombinant human anti-Lewis Y antibodiesLUDWIG INST CANCER RES·Filed 1997·Granted Feb 11, 2003·11 cites·24 claims
- 1859US2014187563A1Combination therapy in treatment of oncological and fibrotic diseasesVAN RYN JOANNE·Filed 2014·Application pending·0 cites
- 1956US5536641AMonoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cellsSLOAN KETTERING INST CANCER·Filed 1994·Granted Jul 16, 1996·10 cites·14 claims
- 2054US2003143229A1FAPalpha -specific antibody with improved producibilityBOEHRINGER INGELHEIM INT·Filed 2002·Application pending·0 cites
- 2153US9274120B2Stratification of pancreatic and ovarian cancer patients for susceptibility to therapy with PTK2 inhibitorsADOLF GUENTHER·Filed 2014·Granted Mar 1, 2016·0 cites·5 claims
- 2253US5437865AIsolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endotheliumSLOAN KETTERING INST CANCER·Filed 1994·Granted Aug 1, 1995·12 cites·4 claims
- 2350US2014066456A1Combination therapy in treatment of cancer and fibrotic diseasesVAN RYN JOANNE·Filed 2013·Application pending·0 cites
- 2450US2003211979A1FAP-activated anti-tumor compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 2546US2003232742A1FAP-activated anti-tumor compoundsFiled 2001·Application pending·0 cites
- 2645US2002155565A1FAP-activated anti-tumor compoundsFiled 2001·Application pending·0 cites
- 2744US5541104AMonoclonal antibodies which bind to tumor rejection antigen precursor mage-1LUDWIG INST CANCER RES·Filed 1994·Granted Jul 30, 1996·8 cites·4 claims
- 2844US2012244141A1Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitorsADOLF GUENTHER·Filed 2011·Application pending·0 cites
- 2943US2002099180A1Human FAP-alpha-specific antibodiesFiled 2001·Application pending·0 cites
- 3043US2003055052A1FAP-activated anti-tumor compoundsFiled 2001·Application pending·0 cites
- 3142US2012136004A1New combination therapy in treatment of cancer and fibrotic diseasesVAN RYN JOANNE·Filed 2010·Application pending·0 cites
- 3241US2012142703A1New combination therapy in treatment of oncological and fibrotic diseasesVAN RYN JOANNE·Filed 2010·Application pending·0 cites
- 3338US5059523ACell-surface glycoproteins of human sarcomasSLOAN KETTERING INST CANCER·Filed 1988·Granted Oct 22, 1991·8 cites·7 claims
- 3430US5618534AIsolated antigen endo glyx-1SLOAN KETTERING INST CANCER·Filed 1995·Granted Apr 8, 1997·0 cites·2 claims
- 3529US5565356AHybridoma cell lines which produce monoclonal antibodies having the properties of monoclonal antibody 100-310 and the monoclonal antibodies produced by these hybridoma cell linesSLOAN KETTERING INST CANCER·Filed 1994·Granted Oct 15, 1996·1 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Pilar Garin-Chesa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →